Viral Hepatitis Research: Updates and Challenges
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Gastroenterology & Hepatology".
Deadline for manuscript submissions: closed (15 October 2023) | Viewed by 13791
Special Issue Editors
Interests: hepatitis
Interests: internal medicine; oncology; hematological malignancies; multiple myeloma; emergency
Special Issues, Collections and Topics in MDPI journals
Interests: pancreatic cancer; pancreatic ductal adenocarcinoma; tumor microenvironment
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is our pleasure to invite you to contribute to the upcoming Special Issue of Medicina, entitled “Viral Hepatitis Research: Updates and Challenges”. The aim of this issue is to review current knowledge on diagnostic and therapeutic hepatitis treatment strategies.
In recent years, measures to eradicate hepatitis B and D have been overshadowed by meaningful advances in hepatitis C therapies. Specifically, there is an ongoing effort to eliminate hepatitis C and meet WHO's ambitious targets by 2030. To meet this target, 90% of people with hepatitis B and/or C should be diagnosed, and 80% of those eligible for treatment should be cured or virally suppressed if they have hepatitis B.
Likewise, the negative impact of the COVID-19 pandemic, and the shift in focus to other viral infections, has endangered hepatitis services and, as a result, the elimination agenda.
Indeed, during this period, only several countries were able to estimate the proportion of people diagnosed with these hepatotropic viruses due to barriers impeding the availability and accessibility of standard healthcare testing services.
The aim of this issue is to catalyze debate on this hot topic and outline the recent advances in biomedical science and immunization approaches. This in turn will, we hope, assist in revitalizing elimination programs and provide care models that can be adapted and developed globally.
All manuscripts will be peer-reviewed in accordance with standard journal policies and procedures.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but not limited to) the following:
- hepatitis B;
- hepatitis C;
- hepatitis D;
- COVID-19;
- epidemiology;
- autoimmunity;
- elimination programs;
- antiviral treatments.
We look forward to receiving your contributions.
Sincerely,
Dr. Endrit Shahini
Dr. Antonio Giovanni Solimando
Dr. Antonella Argentiero
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepatitis B
- hepatitis C
- hepatitis D
- COVID-19
- epidemiology
- autoimmunity
- elimination programs
- antiviral treatments
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.